MedTrace Logo

Effects of Parents Included in Medical Round of Neonatal Intensive Care Unit

NCT05717075 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2026-04-13

No results posted yet for this study

Summary

The goal of this cross-over randomized controlled study is to evaluate the effects of medical rounds with parents. The main questions it aims to answer are:

* How feasible the protocol of this study is to include parents in the medical round?
* Does the Family Round promote the quality of family centered care in the NICU perceived by parents and healthcare staff?
* Does the Family Round promote parent-infant bonding?
* Does the Family Round reduce parents' anxiety?
* Does the Family Round increase parents' satisfaction?
* Does the Family Round improve staff's communication skills to integrate parents in the discussion of medical rounds?

Participants will participate in the Family Round for two weeks, which is organized by healthcare staff following a protocol aiming to integrate parents into the discussion.

They will be compared to the two-week period without the Family Round.

Conditions

  • Family Centered Care
  • Decision Making

Interventions

BEHAVIORAL

Parents Round

The intervention carried out in this study is called Family Round. The Family Round is an additional medical round, aiming to involve parents in the discussion. The basic attitude of the healthcare staff is to make decisions collaboratively with parents or other family members based on the parents' observations of their infant and parents' opinions. As our daily medical round is carried out in the morning between 8 and 10 a.m. and we offer no accommodation for parents in the NICU, the Family Round will be carried out separately in the afternoon. One neonatologist who is in charge of the infant or taking care of the infant on that day will be a facilitator and proceed with the Parent Round according to the protocol. Other healthcare staff are also encouraged to participate, although the number of participants is limited.

Sponsors & Collaborators

  • Nagano Children's Hospital

    lead OTHER

Principal Investigators

  • +81-263-73-6700 Itoshima, MD · Nagano Children's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-05
Primary Completion
2025-10-31
Completion
2025-10-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05717075 on ClinicalTrials.gov